Dry powder inhaler compositions comprising umeclidinium
- 专利权人:
- Glaxo Group Limited
- 发明人:
- Crater, Glenn
- 申请号：
- AU2012266540
- 公开号：
- AU2012266540A1
- 申请日:
- 2012.06.01
- 申请国别(地区):
- AU
- 年份:
- 2014
- 代理人:
- 摘要：
- Dry powder inhalers comprising a muscarinic acetylcholine receptor antagonist and optionally a beta 2 agonist and/or a corticosteroid for use in the treatment of inflammatory or respiratory tract diseases, such as asthma or COPD.
- 来源网站：
- 中国工程科技知识中心
